← Open Payments lookup

APRIL WASHINGTON: Open Payments

NPI 1104441039 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$814 in 42 payments from 10 companies in 2025. Trend: 2023 $709 · 2024 $368 · 2025 $814

Food & beverage: $814
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$193
Vanda Pharmaceuticals Inc.11$172
Alkermes, Inc.5$99
Teva Pharmaceuticals USA, Inc.5$96
ABBVIE INC.4$83
Neurocrine BioSciences, Inc.3$77
Otsuka America Pharmaceutical, Inc.2$35
Supernus Pharmaceuticals, Inc.1$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: COBENFY, FANAPT, VRAYLAR, INGREZZA, UZEDY, ARISTADA, REXULTI, LYBALVI.

Industry payments across GA — which companies pay providers there.